Lexicon Pharmaceuticals Inc (LXRX)
1.70
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
1.705
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Investing (Quarterly): -110.22M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -110.22M |
December 31, 2023 | 51.90M |
September 30, 2023 | -39.33M |
June 30, 2023 | -74.61M |
March 31, 2023 | 12.09M |
December 31, 2022 | 24.17M |
September 30, 2022 | -77.20M |
June 30, 2022 | -13.65M |
March 31, 2022 | -4.408M |
December 31, 2021 | 6.096M |
September 30, 2021 | -0.40M |
June 30, 2021 | 14.14M |
March 31, 2021 | -17.72M |
December 31, 2020 | 44.10M |
September 30, 2020 | 215.80M |
June 30, 2020 | 78.07M |
March 31, 2020 | 42.78M |
December 31, 2019 | -109.40M |
September 30, 2019 | -31.28M |
June 30, 2019 | -7.45M |
March 31, 2019 | -7.726M |
December 31, 2018 | 58.75M |
September 30, 2018 | 56.40M |
June 30, 2018 | 47.37M |
March 31, 2018 | 7.063M |
Date | Value |
---|---|
December 31, 2017 | -135.77M |
September 30, 2017 | 87.05M |
June 30, 2017 | 56.79M |
March 31, 2017 | 42.46M |
December 31, 2016 | 56.46M |
September 30, 2016 | 33.90M |
June 30, 2016 | 61.54M |
March 31, 2016 | -133.64M |
December 31, 2015 | -124.14M |
September 30, 2015 | 77.77M |
June 30, 2015 | 0.34M |
March 31, 2015 | -70.99M |
December 31, 2014 | -170.72M |
September 30, 2014 | 20.51M |
June 30, 2014 | 1.223M |
March 31, 2014 | 40.57M |
December 31, 2013 | 39.77M |
September 30, 2013 | 20.24M |
June 30, 2013 | 10.43M |
March 31, 2013 | 29.11M |
December 31, 2012 | -6.729M |
September 30, 2012 | 11.64M |
June 30, 2012 | 26.86M |
March 31, 2012 | -129.58M |
December 31, 2011 | 18.03M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-110.22M
Minimum
Mar 2024
215.80M
Maximum
Sep 2020
0.1746M
Average
-2.404M
Median
Cash from Investing (Quarterly) Benchmarks
Windtree Therapeutics Inc | -- |
AIM ImmunoTech Inc | -0.158M |
Perspective Therapeutics Inc | -47.30M |
Protalix BioTherapeutics Inc | -0.606M |
Armata Pharmaceuticals Inc | -0.25M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -55.13M |
Cash from Financing (Quarterly) | 239.38M |
Free Cash Flow | -185.41M |
Free Cash Flow Per Share (Quarterly) | -0.2247 |
Free Cash Flow to Equity (Quarterly) | -55.50M |
Free Cash Flow Yield | -46.40% |